What’s next in oncology: Research breakthroughs from the 2025 ASCO® annual meeting

Explore key research and clinical insights from the 2025 ASCO® Annual Meeting, featuring expert analysis from Drs. Ezra Cohen, Sara Tolaney, Nataliya Uboha, and Cynthia Ma.

Aug 14, 2025
Providers
Webinar
Smiling bald man in a suit jacket and white shirt, looking directly at the camera.Ezra CohenChief Medical Officer of Oncology, Tempus,
A black and white headshot of an Asian woman in glasses and a white lab coat.Cynthia X. Ma, MD, PhDProfessor, Medicine, Division of Oncology at Washington University School of Medicine
Black and white headshot of a smiling woman with curly dark hair.Nataliya Uboha, MD, PhDFaculty Leader for Early Phase Oncology Therapeutics Program, Associate Professor, Department of Medicine, Section of Hematology & Oncology, University of Wisconsin
Black and white portrait of a woman with dark hair, wearing a dark top and necklace.Sara TolaneyChief of the Division of Breast Oncology at Dana-Farber Cancer Institute, Associate Professor of Medicine at Harvard Medical School

Session Highlights

  • A cross-functional discussion on what's next in oncology, driven by the latest innovations shaping cancer care

  • Breakthrough research from the 2025 ASCO® Annual Meeting, featuring new clinical data from: SERENA-6, DESTINY-Breast09 and MATTERHORN

  • Insights from Tempus' own ASCO presentation, including new data from the xM MRD assay

  • A look at the evolving role of precision medicine in oncology